🔎 Trials Near Me

Akèy › Neuroblastom › Distrik Columbia › Washington

Etid klinik pou Neuroblastom nan Washington, DC

11 etid pou Neuroblastom ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 5, 2026 · NCT06041516

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
4 Weeks · Tout sèks · Mizajou Oct 2, 2026 · NCT01109394

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ap rekriteFaz 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 a 35 · Tout sèks · Mizajou Sep 24, 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 4 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ap rekriteFaz 3
  • Children's National Medical Center, Washington D.C.
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Ap rekriteFaz 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Laj 1 a 23 · Tout sèks · Mizajou Aug 13, 2026 · NCT07172958

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Etid Neuroblastom nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.